{
    "nctId": "NCT00569166",
    "briefTitle": "Three Different Programs of Paced Breathing in Treating Hot Flashes in Women",
    "officialTitle": "Paced Breathing for Hot Flashes: A Randomized Phase II Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Fatigue, Hot Flashes, Sleep Disorders",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 105,
    "primaryOutcomeMeasure": "The Difference in Hot Flash Score (Frequency and Severity) Between Baseline (Week 1) and Week 9",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* History of breast cancer including ductal carcinoma in situ or lobular carcinoma in situ\n\n  - Treated with surgery and/or adjuvant therapy with a curative intent or patients not preferring to take hormones because of concern for breast cancer\n* Frequent hot flashes (\u2265 14 per week) of sufficient severity to make the patient desire treatment\n* Presence of hot flashes for \u2265 1 month prior to study entry\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1\n* Pre- or post-menopausal\n* Must possess a compact disc (CD) player\n* Able to complete questionnaires alone or with assistance\n* No active medical conditions preventing compliance with a practice of slow deep breathing including active asthma, chronic obstructive pulmonary disease, or congestive heart failure\n* No uncontrolled hypertension (defined as systolic blood pressure (BP) \u2265 160 mm Hg and/or diastolic BP \u2265 100 mm Hg on 2 separate visits)\n\nPRIOR CONCURRENT THERAPY:\n\n* No current (within the past month) practice of yoga or breathing exercises\n* No other concurrent agents for treating hot flashes (e.g., gabapentin, venlafaxine, paroxetine, citalopram, sertraline, natural products such as soy or sage supplements, flaxseed, or black cohosh)\n\n  - Concurrent stable dose antidepressants started within the past 30 days allowed\n* No concurrent hormonal agents and/or antineoplastic chemotherapy - Tamoxifen, raloxifene, and aromatase inhibitors are allowed if patient has been on a constant dose for \u2265 4 weeks and does not plan to stop the treatment during the course of the study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}